Rock2 and Rock3, two new gain-of-function variants of the cytokinin receptors AHK2 and AHK3

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9127073
APP PUB NO 20120272409A1
SERIAL NO

13382922

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to two new gain of function variants of the cytokinin receptor proteins AHK2 and AHK3, namely rock2 and rock3, to transgenic organisms comprising at least one of said new gain-of-function cytokinin receptor variants and to a method for the manufacturing of a transgenic plant comprising at least one of the new gain-of-function variants.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
FREIE UNIVERSITAT BERLIN14195 BERLIN

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bartrina, y Manns Isabel Berlin, DE 2 0
Braun, Helen Berlin, DE 1 0
Schmülling, Thomas Berlin, DE 8 7
Werner, Tomás Berlin, DE 4 1

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 8, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00